24 related articles for article (PubMed ID: 11986949)
1. Neoadjuvant Chemoradiotherapy Changes the Landscape of Soluble Immune Checkpoint Molecules in Patients With Locally Advanced Rectal Cancer.
Liu C; Wang P; Sun Y; Dou X; Hu X; Zou W; Sun Y; Hu Q; Yue J
Front Oncol; 2022; 12():756811. PubMed ID: 35530332
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of circulating miRNAs after alemtuzumab induction therapy in lung transplantation.
Benazzo A; Bozzini S; Auner S; Berezhinskiy HO; Watzenboeck ML; Schwarz S; Schweiger T; Klepetko W; Wekerle T; Hoetzenecker K; Meloni F; Jaksch P
Sci Rep; 2022 Apr; 12(1):7072. PubMed ID: 35490174
[TBL] [Abstract][Full Text] [Related]
3. Biological Characteristics and Clinical Significance of Soluble PD-1/PD-L1 and Exosomal PD-L1 in Cancer.
Niu M; Liu Y; Yi M; Jiao D; Wu K
Front Immunol; 2022; 13():827921. PubMed ID: 35386715
[TBL] [Abstract][Full Text] [Related]
4. Soluble B7-CD28 Family Inhibitory Immune Checkpoint Proteins and Anti-Cancer Immunotherapy.
Khan M; Arooj S; Wang H
Front Immunol; 2021; 12():651634. PubMed ID: 34531847
[TBL] [Abstract][Full Text] [Related]
5. Soluble immune checkpoint molecules: Serum markers for cancer diagnosis and prognosis.
Chakrabarti R; Kapse B; Mukherjee G
Cancer Rep (Hoboken); 2019 Aug; 2(4):e1160. PubMed ID: 32721130
[TBL] [Abstract][Full Text] [Related]
6. Soluble immune checkpoints in cancer: production, function and biological significance.
Gu D; Ao X; Yang Y; Chen Z; Xu X
J Immunother Cancer; 2018 Nov; 6(1):132. PubMed ID: 30482248
[TBL] [Abstract][Full Text] [Related]
7. A soluble form of CTLA-4 is present in paediatric patients with acute lymphoblastic leukaemia and correlates with CD1d+ expression.
Simone R; Tenca C; Fais F; Luciani M; De Rossi G; Pesce G; Bagnasco M; Saverino D
PLoS One; 2012; 7(9):e44654. PubMed ID: 23049754
[TBL] [Abstract][Full Text] [Related]
8. Streptococcus gordonii promotes rapid differentiation of monocytes into dendritic cells through interaction with the sialic acid-binding adhesin.
Urano-Tashiro Y; Yajima A; Takahashi Y; Konishi K
Odontology; 2012 Jul; 100(2):144-8. PubMed ID: 22006240
[TBL] [Abstract][Full Text] [Related]
9. Soluble CD22 as a tumor marker for hairy cell leukemia.
Matsushita K; Margulies I; Onda M; Nagata S; Stetler-Stevenson M; Kreitman RJ
Blood; 2008 Sep; 112(6):2272-7. PubMed ID: 18596230
[TBL] [Abstract][Full Text] [Related]
10. Soluble CD86 protein in serum samples of patients with asthma.
Shi HZ; Xie ZF; Deng JM; Chen YQ; Xiao CQ
Thorax; 2004 Oct; 59(10):870-5. PubMed ID: 15454653
[TBL] [Abstract][Full Text] [Related]
11. Circulating levels and clinical significance of soluble CD40 in patients with hematologic malignancies.
Hock BD; McKenzie JL; Patton NW; Drayson M; Taylor K; Wakeman C; Kantarjian H; Giles F; Albitar M
Cancer; 2006 May; 106(10):2148-57. PubMed ID: 16598754
[TBL] [Abstract][Full Text] [Related]
12. Reconstitution of CD40 and CD80 in dendritic cells generated from blasts of patients with acute myeloid leukemia.
Li L; Schmitt A; Reinhardt P; Greiner J; Ringhoffer M; Vaida B; Bommer M; Vollmer M; Wiesneth M; Döhner H; Schmitt M
Cancer Immun; 2003 Jul; 3():8. PubMed ID: 12862419
[TBL] [Abstract][Full Text] [Related]
13. Human plasma contains a soluble form of CD86 which is present at elevated levels in some leukaemia patients.
Hock BD; Patton WN; Budhia S; Mannari D; Roberts P; McKenzie JL
Leukemia; 2002 May; 16(5):865-73. PubMed ID: 11986949
[TBL] [Abstract][Full Text] [Related]
14. The clinical significance of soluble CD86 levels in patients with acute myeloid leukemia and myelodysplastic syndrome.
Hock BD; McKenzie JL; Patton WN; Haring LF; Yang Y; Shen Y; Estey EH; Albitar M
Cancer; 2003 Oct; 98(8):1681-8. PubMed ID: 14534885
[TBL] [Abstract][Full Text] [Related]
15. Levels of the soluble forms of CD80, CD86, and CD83 are elevated in the synovial fluid of rheumatoid arthritis patients.
Hock BD; O'Donnell JL; Taylor K; Steinkasserer A; McKenzie JL; Rothwell AG; Summers KL
Tissue Antigens; 2006 Jan; 67(1):57-60. PubMed ID: 16451202
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
